Loss of STAT1 from mouse mammary epithelium results in an increased Neu-induced tumor burden.
about
Harnessing Mechanistic Knowledge on Beneficial Versus Deleterious IFN-I Effects to Design Innovative Immunotherapies Targeting Cytokine Activity to Specific Cell TypesDinosaurs and ancient civilizations: reflections on the treatment of cancerInducible, dose-adjustable and time-restricted reconstitution of STAT1 deficiency in vivoSingle-cell tracking of flavivirus RNA uncovers species-specific interactions with the immune system dictating disease outcomeSTAT1 Signaling in Astrocytes Is Essential for Control of Infection in the Central Nervous System.Genetically engineered ERα-positive breast cancer mouse models.High STAT1 mRNA levels but not its tyrosine phosphorylation are associated with macrophage infiltration and bad prognosis in breast cancer.Initiation of metastatic breast carcinoma by targeting of the ductal epithelium with adenovirus-cre: a novel transgenic mouse model of breast cancer.CD95/Fas Increases Stemness in Cancer Cells by Inducing a STAT1-Dependent Type I Interferon Response.The transcriptional STAT3 is a potential target, whereas transcriptional STAT5A/5B/6 are new biomarkers for prognosis in human breast carcinoma.Absence of STAT1 in donor-derived plasmacytoid dendritic cells results in increased STAT3 and attenuates murine GVHDIL-27 is required for shaping the magnitude, affinity distribution, and memory of T cells responding to subunit immunization.A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer.Stat1 stimulates cap-independent mRNA translation to inhibit cell proliferation and promote survival in response to antitumor drugsAbnormal Mammary Development in 129:STAT1-Null Mice is Stroma-Dependent.The interconnectedness of cancer cell signaling.The Role of Interferon Regulatory Factor-1 (IRF1) in Overcoming Antiestrogen Resistance in the Treatment of Breast Cancer.The two faces of Janus kinases and their respective STATs in mammary gland development and cancerPutting the brakes on mammary tumorigenesis: loss of STAT1 predisposes to intraepithelial neoplasias.PDGFRβ signalling regulates local inflammation and synergizes with hypercholesterolaemia to promote atherosclerosis.Adaptive Immune Regulation of Mammary Postnatal OrganogenesisSTAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomasInduction of alternatively activated macrophages enhances pathogenesis during severe acute respiratory syndrome coronavirus infectionThe milk protein α-casein functions as a tumor suppressor via activation of STAT1 signaling, effectively preventing breast cancer tumor growth and metastasis.Programmable nanoparticle functionalization for in vivo targeting.The tumor suppressor function of STAT1 in breast cancerSTAT signaling in mammary gland differentiation, cell survival and tumorigenesisCDK8-mediated STAT1-S727 phosphorylation restrains NK cell cytotoxicity and tumor surveillanceJanus Kinase 1 Is Essential for Inflammatory Cytokine Signaling and Mammary Gland Remodeling.Dysregulated STAT1-SOCS1 control of JAK2 promotes mammary luminal progenitor cell survival and drives ERα(+) tumorigenesis.The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis.The differential interferon responses of two strains of Stat1-deficient mice do not alter susceptibility to HSV-1 and VSV in vivo.The Shc1 adaptor simultaneously balances Stat1 and Stat3 activity to promote breast cancer immune suppression.The spectrum of STAT functions in mammary gland developmentCrosstalk between STAT5 activation and PI3K/AKT functions in normal and transformed mammary epithelial cells.Unsuspected allies: chemotherapy teams up with immunity to fight cancer.Role of STAT1 in the breast.Pathobiology of the 129:Stat1 -/- mouse model of human age-related ER-positive breast cancer with an immune infiltrate-excluded phenotypeOvercoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integrationType III interferon is a critical regulator of innate antifungal immunity.
P2860
Q21131160-BFB27568-07B1-49BF-A628-485FF7E314DDQ24628746-AF654592-88EC-40A8-9F7C-EE83245695BBQ27330038-15DCE1F9-FB2A-4A5B-AF03-87975872A138Q28950496-6D879AEA-C813-4354-9778-03131ED91CC6Q30275440-77BB3A73-6E5F-4064-B69D-7053BA615EA1Q33578641-AA17A1BA-C4E8-40F6-9257-3CE1370DF725Q33611598-4378CC15-DE1F-4766-82E4-8052DA35389EQ33635061-A07FE694-2067-470C-94D8-9DEE92C6DB06Q33809161-FC268C0D-07AC-4672-A3C4-28FB600FFCBFQ33829474-34716C3A-DEC5-49ED-B01F-875EA8323A0BQ34209366-A66D1259-5BD1-4A39-8396-37D4A79C8ECCQ34581324-A45E8CEC-6C51-4C51-9335-E7B91C8217BDQ35274995-77F95A2C-1DEA-400B-B303-3217BE3F0212Q35567160-A206326B-F5D3-4554-A9EC-09E7755E132FQ35663861-8D509A62-B306-4CE6-89F0-50B2DB9AC638Q35669733-BE1C85D1-6D1D-4D74-BB59-A1FFA34FDFD2Q35684410-54CE87EB-8223-480B-AC23-990FB7694E07Q35685851-E0345BE3-CAA8-4BD9-A8B7-3382EE1FD911Q35764332-F1D93BA4-7248-49CA-A2BC-3702B7150F67Q35865871-7F43F654-6C29-4040-A84D-706B8DDCE828Q36070571-1993254B-C355-4955-9294-DFF73A996B1FQ36393153-1AC478BE-77CA-4232-80D2-4789C7B56857Q36414300-81B83172-7946-41D4-9C76-DB9ABE5C7396Q36426497-355946E7-6D51-4DD6-B296-383B11FECDFFQ36482886-21B3776D-0213-4A2C-BE46-47158EB99F52Q37008995-4E898665-3C16-4E91-A314-A5601A081F28Q37107328-A33F8876-DD73-4C6C-8464-57F48EE4CC93Q37107530-7E324379-0E27-47E1-BD23-00383B9150B8Q37122579-8B1622B9-745A-40F0-B336-A582A899FB24Q37475469-18DD11F8-57CC-4927-80B7-005D79F1B04AQ37517621-1DC7F3A1-6CFB-4961-AFCF-F1CF74E8C8A4Q37579607-57392748-A64A-4077-8A77-E86B3A36CF51Q37695311-841F077D-1510-4758-8FDA-A3B46E77B7C7Q38140889-4101A70B-73EC-4D73-9F43-99544D76345FQ39299570-DAFE3ACA-6D70-4C85-9AB4-A2737BECEA96Q39333424-BCC16D0A-A0F4-4D89-A6A4-5AE88C1632FFQ41389851-35F664B3-9F64-42EE-AD39-5FB210AC2D96Q41594948-6C822C61-D8DD-48A8-B657-F0B7514119E3Q41879186-B90D1EEA-C45C-4BB7-98D8-E13712299E84Q41922570-354E9C2E-70A1-414D-B74D-0C972EF8BE40
P2860
Loss of STAT1 from mouse mammary epithelium results in an increased Neu-induced tumor burden.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Loss of STAT1 from mouse mamma ...... ased Neu-induced tumor burden.
@ast
Loss of STAT1 from mouse mamma ...... ased Neu-induced tumor burden.
@en
Loss of STAT1 from mouse mamma ...... ased Neu-induced tumor burden.
@nl
type
label
Loss of STAT1 from mouse mamma ...... ased Neu-induced tumor burden.
@ast
Loss of STAT1 from mouse mamma ...... ased Neu-induced tumor burden.
@en
Loss of STAT1 from mouse mamma ...... ased Neu-induced tumor burden.
@nl
prefLabel
Loss of STAT1 from mouse mamma ...... ased Neu-induced tumor burden.
@ast
Loss of STAT1 from mouse mamma ...... ased Neu-induced tumor burden.
@en
Loss of STAT1 from mouse mamma ...... ased Neu-induced tumor burden.
@nl
P2093
P2860
P356
P1433
P1476
Loss of STAT1 from mouse mamma ...... eased Neu-induced tumor burden
@en
P2093
Daisuke Yamaji
Gertraud W Robinson
Peter J Klover
Ruth M Pfeiffer
William J Muller
P2860
P304
P356
10.1593/NEO.10716
P577
2010-11-01T00:00:00Z